The Architects of Memory and Movement: Who Is Building the Future of Brain Disease Treatment
A handful of pharmaceutical giants — along with a growing cohort of biotechs — have staked their pipelines on Alzheimer's and Parkinson's. Their strategies differ. Their ambitions do not. Image: Shutterstock
More than 55 million people worldwide live with dementia, and nearly 12 million carry a Parkinson’s diagnosis — figures that the World Health Organization projects …
It's free! Log in now to read
LATEST
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan





